thymoquinone has been researched along with Polycystic Ovary Syndrome in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 2 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alaee, S; Bakhtari, A; Derakhshan, Z; Koohpeyma, F; Mirani, M | 1 |
Datta, K; Kumar, S; Saha, P; Tyagi, RK | 1 |
Bidadkosh, A; Eini, F; Ghaffari Novin, M; Joharchi, K; Nazarian, H; Piryaei, A | 1 |
Arif, M; Datta, K; Thakur, SC | 1 |
4 other study(ies) available for thymoquinone and Polycystic Ovary Syndrome
Article | Year |
---|---|
Thymoquinone improves folliculogenesis, sexual hormones, gene expression of apoptotic markers and antioxidant enzymes in polycystic ovary syndrome rat model.
Topics: Animals; Antioxidants; bcl-2-Associated X Protein; Female; Follicle Stimulating Hormone; Gene Expression; Luteinizing Hormone; Polycystic Ovary Syndrome; Rats; Rodent Diseases | 2023 |
Upsurge in autophagy, associated with mifepristone-treated polycystic ovarian condition, is reversed upon thymoquinone treatment.
Topics: Androgens; Animals; Autophagy; Beclin-1; Benzoquinones; Disease Models, Animal; eIF-2 Kinase; Female; Gene Expression Regulation; Granulosa Cells; Humans; Insulin Resistance; Mifepristone; Ovary; Ovulation; Polycystic Ovary Syndrome; Rats; Receptors, Androgen | 2021 |
Thymoquinone reduces intracytoplasmic oxidative stress and improves epigenetic modification in polycystic ovary syndrome mice oocytes, during in-vitro maturation.
Topics: Animals; Benzoquinones; Epigenesis, Genetic; Female; Fertilization in Vitro; Male; Mice; Oocytes; Oxidative Stress; Polycystic Ovary Syndrome | 2019 |
Implication of thymoquinone as a remedy for polycystic ovary in rat.
Topics: Animals; Benzoquinones; Cell Line; Cell Survival; Disease Models, Animal; Female; Inflammation Mediators; Mice; NF-kappa B; Polycystic Ovary Syndrome; Rats; Rats, Wistar | 2016 |